Codexis Stock Price. Everything You Need To Know About The Codexis Stock!
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 248 full-time employees. The company went IPO on 2010-04-22. The firm is engaged in discovering, developing and selling enzymes and other proteins. The firm commercializes its CodeEvolver enzyme engineering technology platform and products in the manufacture of small molecule pharmaceuticals. The company operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Performance Enzymes segment consists primarily of two focus areas: biocatalysts for the sustainable manufacturing of pharmaceuticals, and enzymes for life science applications, including genomic sequencing and nucleic acid synthesis. The Novel Biotherapeutics segment offers product candidates include enzymes that are orally administered for function in the gastrointestinal tract (GI), such as its partnered product candidates CDX-7108 for the treatment of exocrine pancreatic insufficiency and CDX-6114 for the treatment of phenylketonuria, which are both in Phase I clinical trials.
Codexis Stock Price. Everything You Need To Know About The Codexis Stock! performance
- Employees 248
- Company HQ Redwood City
- Website https://www.codexis.com/
- CDXS Asset Type Common Stock
- CDXS Market Capitalization 205.3M
- Earnings Per Share -1.12
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Codexis, a leading biotechnology company, presents a remarkable investment opportunity for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. With its expertise in the fields of structural biology, protein engineering, and biocatalysis, Codexis is transforming industries worldwide. By investing in Codexis stock, you can become a part of their journey towards sustainable solutions and innovative products. To make informed investment decisions, Zorion offers comprehensive investment insights and recommendations about Codexis. Our platform also provides retail investors from Malaysia, Thailand, Indonesia, and Vietnam access to educational materials and resources, empowering them to further their investment knowledge. Unlock the potential of the biotech industry and invest in Codexis today with Zorion.
